Germany has combined its largest biomedical research and development facilities into one super company that is set to gain at minimum €300 million within the next five years. The Berlin Institute of Health (bhi) is now an undisputed leader of European medicine. This past November, key decision makers were on hand in Dusseldorf to spread this announcement at the world’s largest medical trade fair, medica.
The goal of bhi is to court the world’s top-flight scientific and medical minds and use its influential role with federal and state governments, along with university and private research and development.
